David J Stewart

Review Wnt Signaling Pathway in Non–small Cell Lung Cancer Overview of the Wnt Canonical (β-catenin) and Noncanonical Signaling Pathways

D. Stewart, David J Stewart, David J Stewart, 2022 .

The importance of greater speed in drug development for advanced malignancies

Razelle Kurzrock, Mark Clemons, Gerald Batist, 2018, Cancer medicine.

Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Stephen G Swisher, B Nebiyou Bekele, Shyam Biswal, 2010, Clinical Cancer Research.

Cancer research in the United States: A critical review of current status and proposal for alternative models

Razelle Kurzrock, David P Steensma, R. Kurzrock, 2018, Cancer.

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Jian Gu, Joe Y. Chang, Yuanqing Ye, 2011, Journal of the National Cancer Institute.

Novel Therapeutic Targets in Non-small Cell Lung Cancer

Razelle Kurzrock, R. Kurzrock, F. Janku, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Click chemistry, 3D-printing, and omics: the future of drug development

Razelle Kurzrock, R. Kurzrock, D. Stewart, 2015, Oncotarget.

U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009

Razelle Kurzrock, David J Stewart, Sonia K Morgan-Linnell, 2014, Clinical Cancer Research.

Mechanisms of resistance to cisplatin and carboplatin.

D. Stewart, David J Stewart, 2007, Critical reviews in oncology/hematology.

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

Ara A Vaporciyan, Stephen G Swisher, J Jack Lee, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.